Influence of basic fibroblast growth factor on the growth of HeLa cells and the expression of angiogenin

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 949-955

  Yang, Jianli ^a   Wang, Ji ^a   Zhao, Jia ^a   Zuo, Dan ^a   Li, Xingrong ^a   Wang, Li ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

Angiogenin; Basic fibroblast growth factor; HeLa cell; Transfection

Indexed keywords

ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR 2; PANCREATIC RIBONUCLEASE;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; POLYMERASE CHAIN REACTION; RIBONUCLEASE, PANCREATIC; TRANSFECTION;

EID: 67449097419     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000308     Document Type: Article

References (32)

1. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350, 2002.
2. Ozalp S, Yalcin OT, Oner U, Tanir HM, Ackalin M and Sarac I: Microvessel density as a prognostic factor in preinvasive and invasive cervical lesions. Eur J Gynaecol Oncol 24: 425-428, 2003.
3. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF and Vallee BL: Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24: 5480-5486, 1985.
4. Olson KA, Byers HR, Key ME and Fett JW: Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res 7: 3598-3605, 2001.
5. Montero S, Guzman C, Cortes-Funes H and Colomer R: Angiogenin expression and prognosis in primary breast carcinoma. Clin Cancer Res 4: 2161-2168, 1998.
6. Chopra V, Dinh TV and Hannigan EV: Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 16: 152-159, 1998.
7. Li D, Bell J, Brown A and Berry CL: The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas. J Pathol 172: 171-175, 1994.
8. Shimoyama S, Shimizu N, Tsuji E, Yamasaki K, Kawahara M and Kaminishi M: Distribution of angiogenin and its gene message in colorectal cancer patients and their clinical relevance. Anticancer Res 22: 1045-1052, 2002.
9. Chopra V, Dinh TV and Hannigan EV: Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol 123: 167-172, 1997.
10. Shimoyama S and Kaminishi M: Increased angiogenin expression in gastric cancer correlated with cancer progression. J Cancer Res Clin Oncol 126: 468-474, 2000.
11. Moroianu J and Riordan JF: Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci USA 91: 1677-1681, 1994.
12. Xu ZP, Tsuji T, Riordan JF and Hu GF: The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem Biophys Res Commun 294: 287-292, 2002.
13. Xu ZP, Tsuji T, Riordan JF and Hu GF: Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry 42: 121-128, 2003.
14. Tsuji T, Sun Y, Kishimoto K, Olson KA, Liu S, Hirukawa S and Hu GF: Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res 65: 1352-1360, 2005.
15. Basilico C and Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-165, 1992.
16. Montesano R, Vassalli JD, Baird A, Guillemin R and Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83: 7297-7301, 1986.
17. Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z and Yahalom J: Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells. Clin Cancer Res 3: 135-142, 1997.
18. Gross JL, Herblin WF, Dusak BA, Czerniak P, Diamond MD, Sun T, Eidsvoog K, Dexter DL and Yayon A: Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J Natl Cancer Inst 85: 121-131, 1993.
19. Iwasaki A, Kuwahara M, Yoshinaga Y and Shirakusa T: Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. Eur J Cardiothorac Surg 25: 443-448, 2004.
20. Ogasawara S, Yano H, Higaki K, Takayama A, Akiba J, Shiota K and Kojiro M: Expression of angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in human biliary tract carcinoma cell lines. Hepatol Res 20: 97-113, 2001.
21. Alba E, Llombart A, Ribelles N, Ramos M, Fernández R, Mayordomo JI, Tusquets I, Gil M, Barnadas A, Carabante F, Ruiz M, Vera R, Palomero I, Soriano V, González J and Colomer R: Serum endostatin and bFGF as predictive factors in advanced breast cancer patients treated with letrozole. Clin Transl Oncol 8: 193-199, 2006.
22. Gravdal K, Halvorsen OJ, Haukaas SA and Akslen LA: Expression of bFGF/ FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer. Virchows Arch 448: 68-74, 2006.
23. Sliutz G, Tempfer C, Obermair A, Reinthaller A, Gitsch G and Kainz C: Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Lett 94: 227-231, 1995.
24. Kishimoto K, Liu S, Tsuji T, Olson KA and Hu GF: Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 4: 445-456, 2005.
25. Song J, Wang J, Yang J, Jiang C, Shen W and Wang L: Influence of angiogenin on the growth of A375 human melanoma cells and the expression of basic fibroblast growth factor. Melanoma Res 6: 119-126, 2006.
26. Ramírez-Solis R, Rivera-Pérez J, Wallace JD, Wims M, Zheng H and Bradley A: Genomic DNA microextraction: a method to screen numerous samples. Anal Biochem 201: 331-335, 1992.
27. Heydarkhan-Hagvall S, Helenius G, Johansson BR, Li JY, Mattsson E and Risberg B: Co-culture of endothelial cells and smooth muscle cells affects gene expression of angiogenic factors. J Cell Biochem 89: 1250-1259, 2003.
28. Kuhn H, Köff C, Konrad J, Riedel A, Gessner C and Wirtz H: Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines. Lung Cancer 44: 167-174, 2004.
29. Kuhn H, Konrad J, Holtz S, Salameh A, Gessner C, Hammerschmidt S and Wirtz H: Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines. Lung Cancer 54: 149-153, 2006.
30. Polytarchou C, Gligoris T, Kardamakis D, Kotsaki E and Papadimitriou E: X-rays affect the expression of genes involved in angiogenesis. Anticancer Res 24: 2941-2945, 2004.
31. Fersis N, Smyczek-Gargya B, Armeanu S, Gagulic E, Pantic L, Relakis K, Friedrich M and Wallwiener D: Changes in vascular enothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer. Eur J Gynaecol Oncol 25: 45-50, 2004.
32. Kuhn H, Bräunlich J, Hammerschmidt S and Wirtz H: Candidate genes upregulated in density dependent growth inhibition of lung cancer cells. Int J Oncol 25: 1481-1487, 2004.